United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$572.63 for US$5.44M under a trading plan, leaving 40,513 shares. Filed May 1, 2026 (Form 4).

Sold
9,500 shares
Price
US$572.63 average (US$569.54 to US$579.51)
Value
US$5.44M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 30, 2026Common StockSale360US$569.5449,653Direct
Apr 30, 2026Common StockSale1,194US$570.7648,459Direct
Apr 30, 2026Common StockSale3,826US$571.5944,633Direct
Apr 30, 2026Common StockSale1,640US$572.5742,993Direct
Apr 30, 2026Common StockSale928US$573.8542,065Direct
Apr 30, 2026Common StockSale312US$574.7941,753Direct
Apr 30, 2026Common StockSale424US$576.1441,329Direct
Apr 30, 2026Common StockSale316US$577.1041,013Direct
Apr 30, 2026Common StockSale460US$577.9740,553Direct
Apr 30, 2026Common StockSale40US$579.5140,513Direct

Source

View original at SEC

Related